ArticleSurgical endoscopy2025
Outcomes of robotic, laparoscopic, and open surgery across body mass index subgroups for colon and rectal cancer.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Impact of BMI on robotic rectal cancer surgery versus three-dimensional laparoscopic rectal cancer surgery: a retrospective study.Surgical endoscopy · 2026Article
- Reported device problems and patient outcomes in da Vinci robotic robotic gastric and upper-gastrointestinal procedures: an FDA MAUDE database analysis.Journal of robotic surgery · 2026Article
- Global research trends in robotic surgery for rectal cancer: a bibliometric and science-mapping analysis.Journal of robotic surgery · 2026Review
- Robotic-Assisted Surgery for Colorectal Cancer Treatment in 2026: An Updated Narrative Review.Journal of clinical medicine · 2026Review
- Robotic versus laparoscopic surgery for rectal cancer in overweight and obese patients: pathological outcomes, complications, and trial sequential analysis.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundObesity is associated with increased post-operative complications in patients undergoing surgery for colon or rectal cancer. Robotic surgery is increasingly being utilized for obese patients. There is a paucity of research comparing robotic surgery with more traditional approaches across subgroups of patients with varied body mass indices (BMIs).
methodsThe National Surgical Quality Improvement Program (NSQIP) was used for this retrospective study. Patients who underwent open, laparoscopic or robotic surgery for colon or rectal cancer between 2016 and 2022 were included. Patients were stratified by BMI: underweight (< 18.5 kg/m
resultsA total of 52,588 patients were included: 11,437 (21.7%) robotic, 13,302 (25.3%) open, and 27,849 (53.0%) laparoscopic. TO was achieved significantly more often after robotic and laparoscopic procedures compared to open procedures (74.5% and 72.9% vs. 47.8%, respectively; p < 0.001). On regression analysis, robotic surgery was associated with higher achievement of TO across all BMI categories compared to open or laparoscopic surgery. Robotic and laparoscopic surgery were associated with reduced odds of major morbidity compared to open surgery across all BMI categories. Additional subgroup analysis for rectal cancer patients revealed robotic surgery was associated with higher likelihood of TO across all BMI categories. Major morbidity was similar across all surgical approaches for rectal cancer patients with class II and III obesity.
conclusionRobotic surgery is associated with higher likelihood of TO achievement and lower risk of major morbidity across all BMI subgroups. Across all surgical approaches, class II and III obese patients with rectal cancer have comparable rates of major morbidity.
Indexed as
Identifiers
40681650What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.